Medios AG acquires Ceban Pharmaceuticals, expanding its European Specialty Pharma platform.
Medios AG, a leading German Specialty Pharma Solutions provider, acquires Dutch market leader Ceban Pharmaceuticals B.V., a fast-growing pharmaceutical compounding platform operating in the Netherlands, Belgium, and Spain. This acquisition helps Medios internationalize its business model and create a European Specialty Pharma platform. Ceban is expected to generate €160m revenue in 2023 with a €29m EBITDA.
March 18, 2024
8 Articles